Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT04632056
Eligibility Criteria:
Inclusion Criteria:
1. Patients must provide written consent to cooperate in this study before treatment with Beovu kit for intravitreal injection
2. Patients using Beovu kit for intravitreal injection for the first time for the following indication:
* Indication: age-related macular degeneration with subfoveal choroidal neovascularization
Exclusion Criteria:
1\. Patients with a history of treatment with a drug containing the same ingredient (brolucizumab; investigational drug or post-marketing clinical study drug) as Beovu kit for intravitreal injection
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
99 Years
Study:
NCT04632056
Study Brief:
Protocol Section:
NCT04632056